InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Venker Eric, Chief Executive Officer. Officer active across 2 companies, notably Immunovant, Inc.. In total, 87 disclosures have been recorded. Breakdown: 0 buy · 15 sells. Total volume traded: €13m. History available since 25 March 2022. The latest transaction was disclosed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Venker Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations87 total
13,909 shares@ US$36.84Common SharesSEC:0001140361-26-034238:0
200,000 shares@ US$34.950.028% mcap10.4% of flowCommon SharesSEC:0001140361-26-030107:1
200,000 shares@ US$3.850.0031% mcap1.1% of flowCommon SharesSEC:0001140361-26-030107:0
92,188 shares@ US$14.460.017% mcap8.8% of flowCommon StockSEC:0001764013-26-000077:0
86,629 shares@ US$38.140.042% mcap21.7% of flowCommon StockSEC:0001764013-26-000077:1
3,092 shares@ US$38.480.0015% mcap0.8% of flowCommon StockSEC:0001764013-26-000077:2
200,000 shares@ US$3.850.0029% mcap3.1% of flowCommon SharesSEC:0001635088-26-000044:0
200,000 shares@ US$29.590.022% mcap24.1% of flowCommon SharesSEC:0001635088-26-000044:1
232,252 shares0Common StockSEC:0001764013-26-000034:0
368,750 shares@ US$14.460.058% mcap50.0% of flowCommon StockSEC:0001764013-26-000024:0
200,000 shares@ US$3.852.8% of flowCommon SharesSEC:0001635088-26-000026:0
7,051 shares@ US$27.150.4% of flowCommon SharesSEC:0001635088-26-000022:0
200,000 shares@ US$3.851.6% of flowCommon SharesSEC:0001635088-26-000017:0
200,000 shares@ US$3.851.6% of flowCommon SharesSEC:0001140361-26-001239:0
313,841 shares@ US$3.852.6% of flowCommon SharesSEC:0001140361-25-046786:0
200,000 shares@ US$3.851.8% of flowCommon SharesSEC:0001140361-25-045279:0
7,051 shares@ US$20.270.3% of flowCommon SharesSEC:0001140361-25-043201:0
200,000 shares@ US$3.851.8% of flowCommon SharesSEC:0001140361-25-041214:0
414,683 shares@ US$15.8515.5% of flowCommon SharesSEC:0001140361-25-038545:0
104,940 shares@ US$15.854.0% of flowCommon SharesSEC:0001140361-25-038126:0
127,355 shares@ US$15.855.9% of flowCommon SharesSEC:0001140361-25-037740:0
1,000,000 shares@ US$3.8511.9% of flowCommon SharesSEC:0001140361-25-035890:0
7,051 shares@ US$11.720.3% of flowCommon SharesSEC:0001140361-25-032404:0
198,413 shares0Common SharesSEC:0001140361-25-028452:0
100,000 shares@ US$3.851.4% of flowCommon SharesSEC:0001140361-25-027005:0
25 of 87 declarations
About Venker Eric
Venker Eric is Directeur Général and has 84 filings in total. Among the sampled recent filings from 2022-03-29 to 2026-07-06, the sell amount is EUR 9740558, with the main transaction nature listed as Exercise of options. The companies mentioned are Roivant Sciences Ltd., where he is President & Immunovant CEO, and Immunovant, Inc., where he is Chief Executive Officer.
